New study aims to improve pain control for kids after hip surgery
NCT ID NCT07385352
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two medicines, dexmedetomidine and ketamine, added to a standard painkiller (bupivacaine) given through a caudal block to control pain after hip surgery in children aged 1 to 6 years. The goal is to see which combination provides better pain relief, lasts longer, and reduces the need for extra pain medicine. Fifty-four children will take part, and their pain will be measured using a special scale for the first 24 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dexmedetomidine and Ketamine (added to Bupivacaine)
What this could lead to
If it works, this could point toward a safer, longer-lasting pain relief option for children after hip surgery.
What could go wrong
This is a small, early-stage study with only 54 children. It may not show a clear benefit, and results may not apply to all children or surgeries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEVELOPMENTAL DYSPLASIA OF THE HIP are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Assiut University Hospital
Asyut, Asyut Governorate, 71515, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact